About ICE Pharma
ICE Pharma is a Healthcare company based in Alessandria (Italy) founded in 1949. CDMO focused on manufacturing API. The company has 452 employees. Its chief executive, as recorded, is Agostino Barazza. Its Indian entity Raichem Medicare Private Limited reported revenue of ₹515 Cr. ICE Pharma offers products and services including Ursodeoxycholic Acid, CDMO Services, Finished Dosage Forms, and Nutraceutical Supplements. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.
Company details
ICE Pharma was established in 1949 in Alessandria, Italy, where operations as a Contract Development and Manufacturing Organization (CDMO) are conducted. Focus is placed on the production of active pharmaceutical ingredients (API) for the pharmaceutical sector. Services encompass development and manufacturing processes tailored to client specifications. The company maintains its primary facility in Italy, supporting pharmaceutical supply chains across various markets.
- Headquarters Alessandria, Italy
- Employees 452
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website icepharma.com
- Social LinkedIn
- Legal Name Raichem Medicare Private Limited
- Date of Incorporation 01 Jun, 2009
- Jurisdiction Chicksugur Village, Karnataka, India
- Indian entity revenue₹515 Cr
FY 2025 · -12% YoY
- Indian entity net profit₹19.44 Cr
FY 2025 · 4% margin
- Indian entity EBITDA₹52.22 Cr
FY 2025 · 10% margin
- Employee Count452
Associated legal entities of ICE Pharma
ICE Pharma operates through Raichem Medicare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Raichem Medicare Private Limited CIN U24232KA2009PTC049999 | Active | 01 Jun 2009 | Raichur, Karnataka | ₹515 Cr | 210 | 2 | View details |
Products & Services of ICE Pharma
ICE Pharma offers a comprehensive portfolio of products and services, including Ursodeoxycholic Acid, CDMO Services, Finished Dosage Forms, and Nutraceutical Supplements.
Key ingredient for liver disease treatments in pharmaceuticals
Development and production services for pharmaceutical products
Ready-to-use formulations for various medical applications
Branded items focused on immune and gut health support
Board of directors of Raichem Medicare Private Limited (ICE Pharma)
Raichem Medicare Private Limited is the primary company behind ICE Pharma. The board of Raichem Medicare Private Limited currently have 2 directors; the longest-serving is Enzo Bartoli, appointed in 2012. 17 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Enzo Bartoli DIN 02981898 | Director | 30 Jan 2012 | 14 yrs 9 mo | Raichem Medicare Private Limited |
| Agostino Barazza DIN 08830494 | Director | 02 Sep 2020 | 6 yrs 2 mo | Raichem Medicare Private Limited |
People of ICE Pharma
13 people are tracked at ICE Pharma (9 in leadership, 4 in team); the tracked headcount is 452.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership | |
Francesco de Benedictis | Group Chief Financial Officer | Leadership |
Massimo Merlo | Chief Operating Officer | Leadership |
Daniel Maranhão Ferreira | Head Of Finance And Accounting | Leadership |
Roger Viney | Chief Commercial Officer (cco) | Leadership |
Giorgio Testuzza | Head Of HR Italy | Leadership |
Luca Sartorello | Chief Transformation, SC & Sustainability Officer (advent International Portfolio) | Leadership |
Nicola Palumbo | Group Fp&a And Accounting Director | Leadership |
Chiara Mangiarini | Group Human Resources Director | Leadership |
Elisabetta F. | Senior Project Manager | Team |
Paolo Laino | Quality Control Manager | Team |
Tommaso Maino | Group Financial Controller | Team |
Luca Bonafini | Group IT Infrastructure Manager | Team |
Complete people profiles for ICE Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of ICE Pharma
Figures of Raichem Medicare Private Limited, the primary company behind ICE Pharma, for FY 2025. Revenue was ₹515 Cr (-12% year on year). Net profit was ₹19.44 Cr (4% margin). EBITDA was ₹52.22 Cr (10% margin). Revenue has grown at a compounded annual rate of +5% over three years and +12% over five years.
- ₹515 CrRevenue · FY 2025 · -12% YoY
- ₹19.44 CrNet profit · 4% margin
- ₹52.22 CrEBITDA · 10% margin
- ₹1.74 CrPaid-up capital
- 210Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Raichem Medicare Private Limited are on its company page.
Detailed financial statements for ICE Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of ICE Pharma
The website of ICE Pharma (icepharma.com) receives about 6.9K visits a month and ranks #2,430,473 among all websites worldwide, #3,323 in Biotechnology and Pharmaceuticals.
- Monthly visits6.9K
▼ 26.7% vs previous month
- Unique visitors4K
per month
- Global rank#2,430,473
among all websites
- Category rank#3,323
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.6
- Average visit18 sec
- DevicesDesktop 29% · Mobile 71%
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ICE Pharma
ICE Pharma was founded in 1949.
ICE Pharma is headquartered in Alessandria, Italy. It is registered at Alessandria, Piedmont, Italy.
Agostino Barazza is the CEO of ICE Pharma, as recorded in our data.
ICE Pharma has 452 employees.
The primary company behind ICE Pharma, Raichem Medicare Private Limited, reported revenue of ₹515 Cr for FY 2025, down 12% year on year.
ICE Pharma was established in 1949 in Alessandria, Italy, where operations as a Contract Development and Manufacturing Organization (CDMO) are conducted. Focus is placed on the production of active pharmaceutical ingredients (API) for the pharmaceutical sector. Services encompass development and manufacturing processes tailored to client specifications. The company maintains its primary facility in Italy, supporting pharmaceutical supply chains across various markets.
ICE Pharma offers Ursodeoxycholic Acid, CDMO Services, Finished Dosage Forms, and Nutraceutical Supplements.
ICE Pharma operates through Raichem Medicare Private Limited.
The legal entities of ICE Pharma currently have 2 directors, including Agostino Barazza, Enzo Bartoli.